Viatris Inc. (VTRS) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $14.98 (+0.30%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Feb 9, 2026 | Ashwani Verma | UBS | $18.00 | +20.1% |
| Jan 7, 2026 | Les Sulewski | Truist Financial | $16.00 | +6.8% |
| Jul 19, 2024 | Glen Santangelo | Jefferies | $15.00 | +0.1% |
| Mar 28, 2024 | David Amsellem | Piper Sandler | $13.00 | -13.2% |
| Jun 26, 2023 | David Amsellem | Piper Sandler | $10.00 | -33.3% |
| Nov 9, 2022 | Ashwani Verma | UBS | $12.00 | -19.9% |
| Jun 13, 2022 | Ashwani Verma | UBS | $9.00 | -39.9% |
Top Analysts Covering VTRS
VTRS vs Sector & Market
| Metric | VTRS | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.33 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 18 |
| Target Upside | +1.8% | +1150.3% | +14.9% |
| P/E Ratio | -4.86 | 6.87 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $3.61B | $3.66B | $3.69B | 5 |
| 2026-09-30 | $3.80B | $3.84B | $3.87B | 2 |
| 2026-12-31 | $3.73B | $3.77B | $3.80B | 2 |
| 2027-03-31 | $3.36B | $3.40B | $3.42B | 2 |
| 2027-06-30 | $3.67B | $3.71B | $3.73B | 2 |
| 2027-09-30 | $3.86B | $3.90B | $3.92B | 2 |
| 2027-12-31 | $3.82B | $3.86B | $3.89B | 2 |
| 2028-12-31 | $15.07B | $15.15B | $15.22B | 4 |
| 2029-12-31 | $14.78B | $14.97B | $15.11B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.59 | $0.61 | $0.62 | 5 |
| 2026-09-30 | $0.66 | $0.67 | $0.68 | 1 |
| 2026-12-31 | $0.64 | $0.65 | $0.65 | 1 |
| 2027-03-31 | $0.55 | $0.56 | $0.56 | 1 |
| 2027-06-30 | $0.63 | $0.64 | $0.65 | 1 |
| 2027-09-30 | $0.67 | $0.68 | $0.68 | 1 |
| 2027-12-31 | $0.64 | $0.64 | $0.65 | 1 |
| 2028-12-31 | $1.41 | $3.08 | $4.75 | 2 |
| 2029-12-31 | $0.00 | $0.00 | $0.00 | 0 |
Frequently Asked Questions
What is the analyst consensus for VTRS?
The consensus among 3 analysts covering Viatris Inc. (VTRS) is Buy with an average price target of $15.25.
What is the highest price target for VTRS?
The highest price target for VTRS is $18.00, set by Ashwani Verma at UBS on 2026-02-09.
What is the lowest price target for VTRS?
The lowest price target for VTRS is $9.00, set by Ashwani Verma at UBS on 2022-06-13.
How many analysts cover VTRS?
3 analysts have issued ratings for Viatris Inc. in the past 12 months.
Is VTRS a buy or sell right now?
Based on 3 analyst ratings, VTRS has a consensus rating of Buy (2.33/5) with a +1.8% upside to the consensus target of $15.25.
What are the earnings estimates for VTRS?
Analysts estimate VTRS will report EPS of $0.61 for the period ending 2026-06-30, with revenue estimated at $3.66B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.